Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 291

1.

Familial evaluation in catecholaminergic polymorphic ventricular tachycardia: disease penetrance and expression in cardiac ryanodine receptor mutation-carrying relatives.

van der Werf C, Nederend I, Hofman N, van Geloven N, Ebink C, Frohn-Mulder IM, Alings AM, Bosker HA, Bracke FA, van den Heuvel F, Waalewijn RA, Bikker H, van Tintelen JP, Bhuiyan ZA, van den Berg MP, Wilde AA.

Circ Arrhythm Electrophysiol. 2012 Aug 1;5(4):748-56. doi: 10.1161/CIRCEP.112.970517. Epub 2012 Jul 10.

2.

Catecholaminergic polymorphic ventricular tachycardia: RYR2 mutations, bradycardia, and follow up of the patients.

Postma AV, Denjoy I, Kamblock J, Alders M, Lupoglazoff JM, Vaksmann G, Dubosq-Bidot L, Sebillon P, Mannens MM, Guicheney P, Wilde AA.

J Med Genet. 2005 Nov;42(11):863-70.

3.

Search for cardiac calcium cycling gene mutations in familial ventricular arrhythmias resembling catecholaminergic polymorphic ventricular tachycardia.

Marjamaa A, Laitinen-Forsblom P, Lahtinen AM, Viitasalo M, Toivonen L, Kontula K, Swan H.

BMC Med Genet. 2009 Feb 12;10:12. doi: 10.1186/1471-2350-10-12.

4.

Characterization of a novel mutation in the cardiac ryanodine receptor that results in catecholaminergic polymorphic ventricular tachycardia.

Jiang D, Jones PP, Davis DR, Gow R, Green MS, Birnie DH, Chen SR, Gollob MH.

Channels (Austin). 2010 Jul-Aug;4(4):302-10. Epub 2010 Jul 14.

5.

Clinical characteristics and mutational analysis of the RyR2 gene in seven Czech families with catecholaminergic polymorphic ventricular tachycardia.

Andrsova I, Valaskova I, Kubus P, Vit P, Gaillyova R, Kadlecova J, Manouskova L, Novotny T.

Pacing Clin Electrophysiol. 2012 Jul;35(7):798-803. doi: 10.1111/j.1540-8159.2012.03399.x. Epub 2012 Apr 22.

PMID:
22519458
6.

Clinical and molecular characterization of patients with catecholaminergic polymorphic ventricular tachycardia.

Priori SG, Napolitano C, Memmi M, Colombi B, Drago F, Gasparini M, DeSimone L, Coltorti F, Bloise R, Keegan R, Cruz Filho FE, Vignati G, Benatar A, DeLogu A.

Circulation. 2002 Jul 2;106(1):69-74.

7.

Non-ventricular, Clinical, and Functional Features of the RyR2(R420Q) Mutation Causing Catecholaminergic Polymorphic Ventricular Tachycardia.

Domingo D, Neco P, Fernández-Pons E, Zissimopoulos S, Molina P, Olagüe J, Suárez-Mier MP, Lai FA, Gómez AM, Zorio E.

Rev Esp Cardiol (Engl Ed). 2015 May;68(5):398-407. doi: 10.1016/j.rec.2014.04.023. Epub 2014 Nov 29.

PMID:
25440180
8.

Exon 3 deletion of RYR2 encoding cardiac ryanodine receptor is associated with left ventricular non-compaction.

Ohno S, Omura M, Kawamura M, Kimura H, Itoh H, Makiyama T, Ushinohama H, Makita N, Horie M.

Europace. 2014 Nov;16(11):1646-54. doi: 10.1093/europace/eut382. Epub 2014 Jan 6.

PMID:
24394973
9.

Genetic background of catecholaminergic polymorphic ventricular tachycardia in Japan.

Kawamura M, Ohno S, Naiki N, Nagaoka I, Dochi K, Wang Q, Hasegawa K, Kimura H, Miyamoto A, Mizusawa Y, Itoh H, Makiyama T, Sumitomo N, Ushinohama H, Oyama K, Murakoshi N, Aonuma K, Horigome H, Honda T, Yoshinaga M, Ito M, Horie M.

Circ J. 2013;77(7):1705-13. Epub 2013 Apr 18.

10.

Genetic characterization of familial CPVT after 30 years.

Beery TA, Shah MJ, Benson DW.

Biol Res Nurs. 2009 Jul;11(1):66-72. doi: 10.1177/1099800409333369. Epub 2009 Apr 26.

PMID:
19398417
11.

Nationwide experience of catecholaminergic polymorphic ventricular tachycardia caused by RyR2 mutations.

Broendberg AK, Nielsen JC, Bjerre J, Pedersen LN, Kristensen J, Henriksen FL, Bundgaard H, Jensen HK.

Heart. 2017 Jun;103(12):901-909. doi: 10.1136/heartjnl-2016-310509. Epub 2017 Feb 25.

PMID:
28237968
12.

Arrhythmia characterization and long-term outcomes in catecholaminergic polymorphic ventricular tachycardia.

Sy RW, Gollob MH, Klein GJ, Yee R, Skanes AC, Gula LJ, Leong-Sit P, Gow RM, Green MS, Birnie DH, Krahn AD.

Heart Rhythm. 2011 Jun;8(6):864-71. doi: 10.1016/j.hrthm.2011.01.048. Epub 2011 Feb 9.

PMID:
21315846
13.

High prevalence of exercise-induced arrhythmias in catecholaminergic polymorphic ventricular tachycardia mutation-positive family members diagnosed by cascade genetic screening.

Haugaa KH, Leren IS, Berge KE, Bathen J, Loennechen JP, Anfinsen OG, Früh A, Edvardsen T, Kongsgård E, Leren TP, Amlie JP.

Europace. 2010 Mar;12(3):417-23. doi: 10.1093/europace/eup448. Epub 2010 Jan 26.

PMID:
20106799
14.

Left cardiac sympathetic denervation for the management of life-threatening ventricular tachyarrhythmias in young patients with catecholaminergic polymorphic ventricular tachycardia and long QT syndrome.

Schneider HE, Steinmetz M, Krause U, Kriebel T, Ruschewski W, Paul T.

Clin Res Cardiol. 2013 Jan;102(1):33-42. doi: 10.1007/s00392-012-0492-7. Epub 2012 Jul 21.

15.

Clinical and molecular characterization of a cardiac ryanodine receptor founder mutation causing catecholaminergic polymorphic ventricular tachycardia.

Wangüemert F, Bosch Calero C, Pérez C, Campuzano O, Beltran-Alvarez P, Scornik FS, Iglesias A, Berne P, Allegue C, Ruiz Hernandez PM, Brugada J, Pérez GJ, Brugada R.

Heart Rhythm. 2015 Jul;12(7):1636-43. doi: 10.1016/j.hrthm.2015.03.033. Epub 2015 Mar 23.

PMID:
25814417
17.

Mutant ryanodine receptors in catecholaminergic polymorphic ventricular tachycardia generate delayed afterdepolarizations due to increased propensity to Ca2+ waves.

Paavola J, Viitasalo M, Laitinen-Forsblom PJ, Pasternack M, Swan H, Tikkanen I, Toivonen L, Kontula K, Laine M.

Eur Heart J. 2007 May;28(9):1135-42. Epub 2007 Mar 8.

PMID:
17347175
18.

Incidence and risk factors of arrhythmic events in catecholaminergic polymorphic ventricular tachycardia.

Hayashi M, Denjoy I, Extramiana F, Maltret A, Buisson NR, Lupoglazoff JM, Klug D, Hayashi M, Takatsuki S, Villain E, Kamblock J, Messali A, Guicheney P, Lunardi J, Leenhardt A.

Circulation. 2009 May 12;119(18):2426-34. doi: 10.1161/CIRCULATIONAHA.108.829267. Epub 2009 Apr 27.

19.

Active cascade screening in primary inherited arrhythmia syndromes: does it lead to prophylactic treatment?

Hofman N, Tan HL, Alders M, van Langen IM, Wilde AA.

J Am Coll Cardiol. 2010 Jun 8;55(23):2570-6. doi: 10.1016/j.jacc.2009.12.063.

20.

Mutations of the cardiac ryanodine receptor (RyR2) gene in familial polymorphic ventricular tachycardia.

Laitinen PJ, Brown KM, Piippo K, Swan H, Devaney JM, Brahmbhatt B, Donarum EA, Marino M, Tiso N, Viitasalo M, Toivonen L, Stephan DA, Kontula K.

Circulation. 2001 Jan 30;103(4):485-90.

Supplemental Content

Support Center